InventaBioTech, Formerly CytoBioScience, Replaces CEO

San Antonio—The CEO of InventaBioTech, a life sciences business formerly known as CytoBioScience, is stepping down and being replaced by an interim leader.

Jim Garvin, who has been the CEO of Inventa since March 2015, shortly before it moved to San Antonio, TX, from Germany, will remain an active contributor to the business, he wrote in an e-mail this morning. Garvin’s responsibility was to establish Inventa in the U.S. and get it onto a “public platform,” he wrote. Steven Charest, a New York investment banking executive, is taking over as the interim CEO.

Last year, when the San Antonio business Read more »

READ  Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact

Leave a Reply